Lv33
260 积分 2026-07-03 加入
From breakthroughs to blueprints: evolving evidence and future directions in relapsed and refractory large B-cell lymphoma
2天前
已完结
The landscape of genetic medicines for in vivo T cell reprogramming
2天前
已完结
FGF21 gene therapy for healthy aging: Great promise, important questions
15天前
已完结
Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial
1个月前
已完结
“Just right” AAV gene therapy for spinal muscular atrophy
1个月前
已完结
皖公网安备34019202002308
